Physician profile
Sam Delk
NPI 1922026707
$1,806.17
in general payments reported to CMS, 2019-2025
7 companies · $235 in 2025
The $235 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137 · 2020: $121 · 2021: $11.82 · 2022: $508 · 2023: $394 · 2024: $400 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,028.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,028.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,510.91 | 2019-2025 | Collagenase Santyl, Grafix Pl, Grafix |
| Biotissue Holdings INC. | $214.07 | 2022-2025 | |
| Ethicon US, LLC | $24.62 | 2023 | Surgiflo Hemostatic Matrix |
| Misonix INC | $22.46 | 2019 | |
| Organogenesis INC. | $17.31 | 2025 | Puraply Wound Matrix |
| Advanced Oxygen Therapy INC. | $8.67 | 2025 | Topical Oxygen Chamber For Extremities |
| Kerecis Limited | $8.13 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sam Delk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.